JP5646990B2 - 幹細胞自己複製のための方法及び組成物 - Google Patents
幹細胞自己複製のための方法及び組成物 Download PDFInfo
- Publication number
- JP5646990B2 JP5646990B2 JP2010506243A JP2010506243A JP5646990B2 JP 5646990 B2 JP5646990 B2 JP 5646990B2 JP 2010506243 A JP2010506243 A JP 2010506243A JP 2010506243 A JP2010506243 A JP 2010506243A JP 5646990 B2 JP5646990 B2 JP 5646990B2
- Authority
- JP
- Japan
- Prior art keywords
- pten
- inhibitor
- cells
- gsk
- hsc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Diabetes (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92606507P | 2007-04-23 | 2007-04-23 | |
| US60/926,065 | 2007-04-23 | ||
| US6669308P | 2008-02-22 | 2008-02-22 | |
| US61/066,693 | 2008-02-22 | ||
| PCT/US2008/005230 WO2008133904A1 (en) | 2007-04-23 | 2008-04-23 | Methods and compositions for stem cell self-renewal |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014125145A Division JP2014195464A (ja) | 2007-04-23 | 2014-06-18 | 幹細胞自己複製のための方法及び組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010524499A JP2010524499A (ja) | 2010-07-22 |
| JP2010524499A5 JP2010524499A5 (cg-RX-API-DMAC7.html) | 2011-06-23 |
| JP5646990B2 true JP5646990B2 (ja) | 2014-12-24 |
Family
ID=39925972
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010506243A Active JP5646990B2 (ja) | 2007-04-23 | 2008-04-23 | 幹細胞自己複製のための方法及び組成物 |
| JP2014125145A Pending JP2014195464A (ja) | 2007-04-23 | 2014-06-18 | 幹細胞自己複製のための方法及び組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014125145A Pending JP2014195464A (ja) | 2007-04-23 | 2014-06-18 | 幹細胞自己複製のための方法及び組成物 |
Country Status (4)
| Country | Link |
|---|---|
| US (8) | US8263403B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2798956A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP5646990B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2008133904A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2798956A1 (en) * | 2007-04-23 | 2014-11-05 | Stowers Institute for Medical Research | Methods and compositions for hematopoeitic stem cell self-renewal |
| US20110076254A1 (en) * | 2009-09-28 | 2011-03-31 | University Of Washington | Porous scaffolds for stem cell renewal |
| US9050315B2 (en) * | 2010-04-12 | 2015-06-09 | The Trustees Of The University Of Pennsylvania | In vivo and ex vivo expansion of hematopoietic stem cells with a targeted combination of clinically tested, FDA approved drugs |
| CN102234627B (zh) * | 2010-04-30 | 2015-06-03 | 中国科学院广州生物医药与健康研究院 | 一种培养基添加剂及其应用 |
| WO2011159359A2 (en) | 2010-06-17 | 2011-12-22 | Stemrd, Inc. | Serum-free chemically defined cell culture medium |
| WO2012131733A2 (en) * | 2011-03-31 | 2012-10-04 | Godavari Biorefineries Limited | Media compositions, method of initiating and enriching cultures of stem cells and/or cancer stem-like cells |
| US9157908B2 (en) | 2011-04-22 | 2015-10-13 | University Of Washington Through Its Center For Commercialization | Chitosan-alginate scaffold cell culture system and related methods |
| WO2012175633A1 (en) | 2011-06-21 | 2012-12-27 | Novo Nordisk A/S | Efficient induction of definitive endoderm from pluripotent stem cells |
| CN102250830B (zh) * | 2011-07-05 | 2013-01-16 | 西北农林科技大学 | 一种雌性生殖干细胞的体外分离及培养方法 |
| JP2014526887A (ja) * | 2011-08-01 | 2014-10-09 | アルナイラム ファーマシューティカルズ, インコーポレイテッド | 造血幹細胞移植の成功率を改善する方法 |
| US9896659B2 (en) * | 2011-10-19 | 2018-02-20 | Stowers Institute For Medical Research | Methods, kits, and compositions for stem cell self-renewal |
| WO2013173688A1 (en) * | 2012-05-18 | 2013-11-21 | The Cooper Health System | A method of making tissue engineered blood vessels and generating capillary networks, articles, and methods of use thereof |
| GB201210857D0 (en) | 2012-06-19 | 2012-08-01 | Cambridge Entpr Ltd | Transcription factor mediated programming towards megakaryocytes |
| CA2896053A1 (en) | 2012-12-21 | 2014-06-26 | Ocata Therapeutics, Inc. | Methods for production of platelets from pluripotent stem cells and compositions thereof |
| WO2014144423A2 (en) * | 2013-03-15 | 2014-09-18 | Techulon Inc. | Antisense molecules for treatment of staphylococcus aureus infection |
| NZ715302A (en) | 2013-06-14 | 2021-12-24 | Univ Queensland | Renal progenitor cells |
| US20150250824A1 (en) * | 2014-03-07 | 2015-09-10 | The Research Foundation For The State University Of New York | Methods and compositions for expansion of stem cells and other cells |
| JP6502323B2 (ja) * | 2014-03-26 | 2019-04-17 | 国立大学法人京都大学 | 多能性幹細胞培養用培地 |
| CN105441384B (zh) * | 2014-09-26 | 2021-01-05 | 北京大学 | 一种制备动物和人类原始多潜能干细胞的方法,试剂盒及用途 |
| EP3263697B1 (en) * | 2015-02-27 | 2021-03-31 | Rohto Pharmaceutical Co., Ltd. | Culture medium for culturing mesenchymal stem cell, method for culturing mesenchymal stem cell, and mesenchymal stem cell |
| US20180360025A1 (en) * | 2015-07-22 | 2018-12-20 | Ramot At Tel-Aviv University Ltd. | Article of manufacture and methods for increasing survival of red blood cells |
| WO2017079632A1 (en) * | 2015-11-04 | 2017-05-11 | Cedars-Sinai Medical Center | Patient-derived ctc-xenograft models |
| WO2017139381A1 (en) | 2016-02-08 | 2017-08-17 | University Of Iowa Research Foundation | Methods to produce chimeric adeno-associated virus/bocavirus parvovirus |
| WO2017155973A1 (en) | 2016-03-07 | 2017-09-14 | University Of Iowa Research Foundation | Aav-mediated expression using a synthetic promoter and enhancer |
| US10688136B2 (en) * | 2016-05-20 | 2020-06-23 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions to maintain stem cell quiescence |
| US12173305B2 (en) | 2016-05-26 | 2024-12-24 | University Of Iowa Research Foundation | cis and trans requirements for terminal resolution of human bocavirus 1 |
| AU2017335841A1 (en) | 2016-09-28 | 2019-04-04 | Organovo, Inc. | Use of engineered renal tissues in assays |
| US11142775B2 (en) | 2017-01-13 | 2021-10-12 | University Of Iowa Research Foundation | Bocaparvovirus small noncoding RNA and uses thereof |
| WO2018217567A1 (en) * | 2017-05-22 | 2018-11-29 | Transfusion Health, Llc | Compositions and methods of making expanded hematopoietic stem cells using pten inhibitors |
| WO2019074980A1 (en) * | 2017-10-09 | 2019-04-18 | Stowers Institute For Medical Research | METHODS AND COMPOSITIONS FOR EXPANSION OF CELL POPULATION |
| EP3700334B1 (en) * | 2017-10-27 | 2026-04-08 | Immunebridge Inc. | Compositions and methods of making expanded hematopoietic stem cells using derivatives of fluorene |
| KR102010922B1 (ko) * | 2017-11-01 | 2019-08-14 | 가톨릭관동대학교산학협력단 | 켄파울론 유도체의 줄기세포의 심근세포로의 분화 유도 용도 |
| CN107630002A (zh) * | 2017-11-03 | 2018-01-26 | 广州市天河诺亚生物工程有限公司 | 一种脐带血造血干细胞的扩增方法 |
| US20210255170A1 (en) * | 2018-03-13 | 2021-08-19 | University Of Iowa Research Foundation | Inductive regeneration of the airway by transcriptional factor modulation of glandular myoepithelial stem cells |
| CN108277203B (zh) * | 2018-04-08 | 2020-07-24 | 浙江大学 | 一种体外维持人造血干祖细胞干性的培养基及方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990010448A2 (en) | 1989-03-07 | 1990-09-20 | Genentech, Inc. | Covalent conjugates of lipid and oligonucleotide |
| WO1991004753A1 (en) | 1989-10-02 | 1991-04-18 | Cetus Corporation | Conjugates of antisense oligonucleotides and therapeutic uses thereof |
| US5958769A (en) | 1996-01-18 | 1999-09-28 | Fred Hutchinson Cancer Research Center | Compositions and methods for mediating cell cycle progression |
| US5851984A (en) * | 1996-08-16 | 1998-12-22 | Genentech, Inc. | Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides |
| US6159462A (en) * | 1996-08-16 | 2000-12-12 | Genentech, Inc. | Uses of Wnt polypeptides |
| US6962698B1 (en) | 1998-02-17 | 2005-11-08 | Gamida Cell Ltd. | Methods of controlling proliferation and differentiation of stem and progenitor cells |
| US7018801B2 (en) | 2000-02-11 | 2006-03-28 | Board Of Regents, The University Of Texas System | Selection of peptides with antibody-like properties |
| IL152904A0 (en) | 2002-01-24 | 2003-06-24 | Gamida Cell Ltd | Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations |
| CA2495824A1 (en) * | 2002-08-19 | 2004-02-26 | Gamida-Cell Ltd. | Ex-vivo expansion of hematopoietic stem cell populations in mononuclear cell cultures |
| AU2003295444A1 (en) * | 2002-11-15 | 2004-06-15 | The Board Of Trustees Of The University Of Illinois | Methods for in vitro expansion of hematopoietic stem cells |
| US20050054097A1 (en) * | 2002-11-17 | 2005-03-10 | Tony Peled | EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures |
| AU2003294499A1 (en) | 2002-11-25 | 2004-06-18 | Exelixis, Inc. | Rhebs as modifiers of the rb pathway and methods of use |
| EP1601759A4 (en) * | 2003-03-07 | 2007-02-14 | Gamida Cell Ltd | EXPANSION OF RENEWABLE STEM CELL POPULATIONS USING PI-3 KINASE MODULATORS |
| US7510877B2 (en) * | 2003-09-26 | 2009-03-31 | The Regents Of The University Of Michigan | Hematopoietic stem cell identification and isolation |
| US20070065447A1 (en) | 2003-10-29 | 2007-03-22 | Novo Nordisk A/S | Laminin-5 gamma2-binding peptides, related compositions, and use thereof |
| WO2006027545A2 (en) | 2004-09-10 | 2006-03-16 | Agency For Science, Technology And Research | Method |
| WO2006030442A2 (en) | 2004-09-16 | 2006-03-23 | Gamida-Cell Ltd. | Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells |
| US7850960B2 (en) * | 2004-12-30 | 2010-12-14 | University Of Washington | Methods for regulation of stem cells |
| EP1705949A1 (en) * | 2005-03-22 | 2006-09-27 | Sony Ericsson Mobile Communications AB | An electroacoustic device |
| JP2009532017A (ja) | 2006-02-10 | 2009-09-10 | ザ レジェンツ オブ ザ ユニヴァースティ オブ カリフォルニア | PTD/CPPSへのdsRNA結合ドメイン融合体によるsiRNAの導入可能な送達 |
| EP1999255A2 (en) | 2006-03-24 | 2008-12-10 | The Children's Medical Center Corporation | Method to modulate hematopoietic stem cell growth |
| CN102911989B (zh) * | 2006-11-01 | 2015-07-22 | 罗格斯,新泽西州立大学 | 脐带血干细胞增殖和生长因子产生的锂刺激 |
| EP2798956A1 (en) | 2007-04-23 | 2014-11-05 | Stowers Institute for Medical Research | Methods and compositions for hematopoeitic stem cell self-renewal |
| US9896659B2 (en) * | 2011-10-19 | 2018-02-20 | Stowers Institute For Medical Research | Methods, kits, and compositions for stem cell self-renewal |
-
2008
- 2008-04-23 EP EP14176535.4A patent/EP2798956A1/en not_active Withdrawn
- 2008-04-23 US US12/451,038 patent/US8263403B2/en active Active
- 2008-04-23 EP EP08743210.0A patent/EP2148569B1/en active Active
- 2008-04-23 WO PCT/US2008/005230 patent/WO2008133904A1/en not_active Ceased
- 2008-04-23 JP JP2010506243A patent/JP5646990B2/ja active Active
-
2009
- 2009-10-23 US US12/589,551 patent/US20100099186A1/en not_active Abandoned
-
2010
- 2010-06-16 US US12/802,913 patent/US20110053266A1/en not_active Abandoned
-
2012
- 2012-08-09 US US13/570,534 patent/US8476071B2/en active Active
-
2013
- 2013-05-20 US US13/897,544 patent/US9771559B2/en active Active
-
2014
- 2014-06-18 JP JP2014125145A patent/JP2014195464A/ja active Pending
-
2015
- 2015-02-27 US US14/634,540 patent/US10787643B2/en active Active
-
2016
- 2016-05-17 US US15/156,851 patent/US20160355784A1/en not_active Abandoned
-
2017
- 2017-08-22 US US15/683,276 patent/US20180072991A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008133904A1 (en) | 2008-11-06 |
| US20110053266A1 (en) | 2011-03-03 |
| US20100099186A1 (en) | 2010-04-22 |
| JP2010524499A (ja) | 2010-07-22 |
| EP2798956A1 (en) | 2014-11-05 |
| JP2014195464A (ja) | 2014-10-16 |
| US10787643B2 (en) | 2020-09-29 |
| EP2148569A4 (en) | 2011-02-16 |
| EP2148569A1 (en) | 2010-02-03 |
| US20120309088A1 (en) | 2012-12-06 |
| US20130252338A1 (en) | 2013-09-26 |
| US8263403B2 (en) | 2012-09-11 |
| US20180072991A1 (en) | 2018-03-15 |
| US20100196337A1 (en) | 2010-08-05 |
| US20160355784A1 (en) | 2016-12-08 |
| US9771559B2 (en) | 2017-09-26 |
| US20150344845A1 (en) | 2015-12-03 |
| US8476071B2 (en) | 2013-07-02 |
| EP2148569B1 (en) | 2014-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014195464A (ja) | 幹細胞自己複製のための方法及び組成物 | |
| Hur et al. | CD82/KAI1 maintains the dormancy of long-term hematopoietic stem cells through interaction with DARC-expressing macrophages | |
| Lévesque et al. | The endosteal ‘osteoblastic’niche and its role in hematopoietic stem cell homing and mobilization | |
| Butler et al. | Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells | |
| JP2023171952A (ja) | 細胞集団を増大させるための方法および組成物 | |
| US9896659B2 (en) | Methods, kits, and compositions for stem cell self-renewal | |
| JP2022113722A (ja) | ヒト造血幹/前駆細胞のエクスビボ拡大のための組成物および方法 | |
| KR101218663B1 (ko) | 줄기세포 및 전구세포 분화의 조절, 측정 및 이들의 용도 | |
| Famili et al. | Discrete roles of canonical and non-canonical Wnt signaling in hematopoiesis and lymphopoiesis | |
| JP6669762B2 (ja) | 移植後の造血幹細胞の生着効率の増進に使用するための組成物 | |
| US20050158857A1 (en) | Hematopoietic stem cell identification and isolation | |
| WO2010138873A1 (en) | Long term expansion of human hematopoietic stem cells | |
| Semedo et al. | Targeting the bone marrow niche, moving towards leukemia eradication | |
| WO2019147916A1 (en) | Methods and system of human hemogenic reprogramming | |
| Deutsch et al. | Mimicking the haematopoietic niche microenvironment provides a novel strategy for expansion of haematopoietic and megakaryocyte‐progenitor cells from cord blood | |
| CN110551688A (zh) | 一种诱导体细胞重编程为造血干/祖细胞且促进造血干/祖细胞体外扩增的组合物及其应用 | |
| Casetti | New roles of STAT5 factors in chronic myeloid leukemia cell maintenance | |
| Zerbst | An investigation into the role of autophagy in mediating leukaemic cell location in the bone marrow niche | |
| Dhami | Identifying novel drug therapies for acute myeloid leukaemia by targeting the interactions between leukaemia cells and bone marrow microenvironment | |
| Halvarsson | Hypoxia-inducible factor 1 alpha-dependent and independent regulation of hematopoietic stem cells and leukemia | |
| Tanaskovic | Lack of p21 expression in tumor-associated APCs triggers the activation of a potent anti-tumor immune response | |
| Luo | The role of endoplasmic reticulum chaperones in regulating hematopoietic stem cells and hematological malignancies | |
| HK40031696A (en) | Methods and compositions for expansion of cell population | |
| HK40031696B (en) | Methods and compositions for expansion of cell population | |
| Al Ajmi | Role of oxidative stress and telomerase on haematopoietic stem and progenitor cell ageing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110425 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110425 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120322 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130326 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130626 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140218 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140618 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20140818 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20141007 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20141106 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5646990 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |